Ann Herman
Publications by Year
Research Areas
T-cell and B-cell Immunology, Immune Cell Function and Interaction, Multiple Sclerosis Research Studies, Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → CD4+CD25+ T Regulatory Cells Dependent on ICOS Promote Regulation of Effector Cells in the Prediabetic Lesion(2004)449 cited
- → Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis(2020)336 cited
- → Where CD4 + CD25 + T reg cells impinge on autoimmune diabetes(2005)263 cited
- → Inhibition of DYRK1A and GSK3B induces human β-cell proliferation(2015)200 cited
- → Rational design of small molecules as vaccine adjuvants(2014)176 cited
- → Small-Molecule Inducer of β Cell Proliferation Identified by High-Throughput Screening(2013)97 cited
- → Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials(2023)81 cited
- → Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO(2020)78 cited
- → Gene expression microarrays: glimpses of the immunological genome(2006)75 cited
- → Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Volunteers Treated With GDC‐0853, a Selective Reversible Bruton's Tyrosine Kinase Inhibitor(2018)65 cited